Monday, January 24, 2022 6:35:34 PM
Recent BFRI News
- Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/13/2024 10:15:00 PM
- Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC) • GlobeNewswire Inc. • 10/31/2024 02:32:00 PM
- Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC) • GlobeNewswire Inc. • 10/14/2024 02:30:00 PM
- FDA Approves Use of Up To Three Tubes of Biofrontera Inc.’s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One Treatment • GlobeNewswire Inc. • 10/07/2024 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:49:13 PM
- Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 08/14/2024 08:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:15:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:52:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:52:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:52:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:52:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:52:10 PM
- Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/08/2024 10:14:05 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 03/05/2024 10:20:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 02:26:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 02:37:27 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 02/20/2024 12:55:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 10:25:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:30:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:30:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 09:40:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/09/2024 10:01:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:27:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 10:25:20 PM
FEATURED Key Metals Surge, Unlocking New Opportunities for Savvy Mining Investors • Nov 19, 2024 8:45 AM
FEATURED Greenlane Signs New U.S. Distribution Agreement with Veriteque USA, Manufacturer of the SwabTek™ and Verifique™ Brand of Field Test Kits • Nov 19, 2024 8:34 AM
FEATURED Are we about to see a comeback? Steakholder Foods Charges Forward with New Commitments from Multiple International Players as it Transitions to Revenue Generation • Nov 18, 2024 11:56 AM
Geo-Political Tensions and Trump's Increasing Military Budgets Could Boost Demand for Actelis' Cyber Hardened Networking Tech ($ASNS) • ASNS • Nov 19, 2024 10:24 AM
CBD Life Sciences Inc. (CBDL) Closes on LOI for Potential $8 Million Revenue Cannabis Dispensary • CBDL • Nov 19, 2024 8:00 AM
North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California • NBRI • Nov 18, 2024 9:00 AM